| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT02171546 Details | 2014-06-24 Interventional | 1 | 42 | Dabigatran Fexofenadine Quinidine Quinidine gluco… Healthy | - - | |||
| NCT01534806 Details | 2014-06-24 Interventional | 4 | 0 | Ketorolac Emergencies Migraine Disord… Migraine | Drug is backordered; - | |||
| NCT01435902 Details | 2014-06-23 Interventional | 3 | 0 | Fluticasone Xhance Asthma | Study was cancelled prior to enrolling any subjects - | |||
| NCT01360827 Details | 2014-06-17 Interventional | 1 | 13 | Cetuximab Cisplatin Fluorouracil Carcinoma Carcinoma, Squa… Squamous Cell C… Squamous Cell C… | Study terminated due to potential safety concerns in combination with platinum-based therapies - | |||
| NCT00227292 NCT00294333 2005-001673-10 Details | 2014-06-17 Interventional | 4 | [2 Refs] | 0 | Escitalopram Back Pain Depression Low Back Pain | Mutual agreement between Sponsor and Investigator. - | ||
| NCT00000372 Details | 2014-06-12 Interventional | 3 | 0 | Clozapine Cycloserine Glycine Schizophrenia | Pairing D-Cycloserine with Clozapine was found to worsen negative side effects in patients with
Schizophrenia, so the study was suspended. - | |||
| NCT01254656 Details | 2014-06-09 Interventional | 2 | 108 | Efavirenz Etravirine Infections HIV-1 | See termination reason in detailed description. The study was terminated on 29 Jan 13 due to termination of lersivirine development program. All participants were enrolled from study A5271015 except one from A5271022. Above summarized outcome measures included participants enrolled from A5271015. | |||
| NCT01252355 2010-023172-12 Details | 2014-06-09 Interventional | 3 | 534 | Interferon-beta Interferons Teriflunomide Multiple Sclero… Sclerosis Multiple Sclero… | Sponsor decision to prematurely stop the study, not linked to any safety concern. The early termination of study with reduced sample size and participant follow-up impacts the power and interpretability, and limits the ability to assess the overall benefit/risk of adjunctive therapy. Termination was not due to any safety concerns. | |||
| NCT01149993 Details | 2014-06-09 Interventional | 4 | 0 | Antilymphocyte … Mycophenolic Ac… Thymoglobulin Ischemia Reperfusion Inj… Wounds and Inju… Kidney Transpla… Renal Transplan… | FDA clinical hold, IND withdrawn. - | |||
| NCT00729833 Details | 2014-06-09 Interventional | 1 | 45 | Sunitinib Neoplasms Advanced Cancer Advanced Solid … | See termination reason in detailed description. This study was terminated prematurely. Subsequently, ADA samples were not assayed and the pharmacokinetics of sunitinib plus its metabolite were not analyzed. | |||
| NCT00689052 Details | 2014-06-09 Interventional | 2 | 61 | Dexpramipexole Pramipexole Fibromyalgia Myofascial Pain… | - Early termination leading to no number of subjects analysed for any outcome measure | |||
| NCT00603525 Details | 2014-06-09 Interventional | 3 | 169 | Ofatumumab Arthritis Arthritis, Rheu… | Ofatumumab IV trials in RA were prematurely terminated because GSK refocused clinical
development of autoimmune indications on the subcutaneous delivery. - | |||
| NCT00114374 Details | 2014-06-09 Interventional | 3 | - | Escitalopram Anxiety Disorde… Stress Disorder… Stress Disorder… Wounds and Inju… Anxiety Disorde… | - - | |||
| NCT00087373 Details | 2014-06-09 Interventional | 2 | 28 | Metronidazole Melanoma Recurrent Melan… Stage IV Melano… | - - | |||
| NCT00956293 2008-005109-20 Details | 2014-06-06 Interventional | 4 | 207 | Basiliximab Cyclosporine Cyclosporins Everolimus Mycophenolic Ac… Renal Transplan… | The study was terminated because the required sample size of 240-260 de novo senior renal
transplant patients was not achieved within a reasonable time. - | |||
| NCT00628355 Details | 2014-06-06 Interventional | 4 | 30 | Lidocaine Myofascial Pain… Pelvic Pain | Lidocaine injection group showed significant improvement in pain Early termination leading to small numbers of subjects analyzed. | |||
| NCT01533818 Details | 2014-06-03 Interventional | 4 | 963 | Amoxicillin Respiratory Asp… Tachypnea Fast Breathing … | The study was stopped by DSMB based on high treatment failure rate in placebo compared to
active drug. - | |||
| NCT01231854 2009-017520-88 Details | 2014-06-03 Interventional | 4 | 15 | Alitretinoin Cyclosporine Cyclosporins Dermatitis Atopic Dermatit… | delayed start of the trial, both treatment options already have market authorizations, study
medication expired - | |||
| NCT00198172 Details | 2014-06-03 Interventional | 2 | - | Epirubicin Neoplasms, Germ… Germ Cell Tumor | Accrual Goal Met - | |||
| NCT02055196 Details | 2014-06-02 Interventional | 1 | 0 | Irinotecan Astrocytoma Glioblastoma Gliosarcoma Oligodendroglio… Recurrence Adult Anaplasti… Adult Anaplasti… Adult Giant Cel… Adult Glioblast… Adult Gliosarco… Recurrent Adult… | New study written - |